首页> 中文期刊>中国循环杂志 >闭式体外循环辅助下经右胸前外侧小切口微创心脏外科手术的临床总结

闭式体外循环辅助下经右胸前外侧小切口微创心脏外科手术的临床总结

     

摘要

Objective: To summarize the short-term clinical experience of minimally invasive direct cardiac surgery (MIDCS) with right anterolateral thoracotomy incision by closed cardiopulmonary bypass. Methods: A total of 42 patients received MIDCS in our hospital from 2013-09 to 2015-05 were summarized. There were 18 male and 24 female patients including 16 with atrial septal defect (ASD) repair, 4 with ventricular septal defect (VSD) repair, 16 with mitral valve replacement (MVR), 1 with mitral valve plasty (MVP) and 5 with aortic valve replacement (AVR). Direct cardiac surgery was performed by cardiopulmonary bypass through femoral artery-vein and right jugular vein annulations. A right anterolateral thoracotomy incision (length 3-5 cm) was made to enter the chest and complete the operation. Results: All 42 patients received successful operation, no peri-operative or early post-operative death, no incision infection occurred. Cardiopulmonary bypass time was [98-142 (122.4 ± 23.7) min], aortic cross-clamp time [0-118 (48.3 ± 26.2) min]. Post-operative mechanical ventilation time was [8-76 (17.4±13.1) h], intensive care unit stay time [45-124, (54.6 ± 32.6) h], hospital stay time [6-12, (8.2 ± 1.3) d]. Incision length was [3-7, (4.8 ± 1.5) cm], the draining volume at the 1st post-operative day was (356.9 ± 283.8) ml and there were 27 (64.3%) patients without transfusion. Conclusion: The short-term outcomes for MIDCS were good, it with superior safety, broad application range with minimal invasion and less complication.%目的:总结微创直视心脏外科手术(MIDCS)的近期临床效果。方法:2013-09至2015-05我院完成MIDCS 42例,其中男18例,女24例。房间隔缺损修补术16例,室间隔缺损修补术4例,二尖瓣置换术16例,二尖瓣成形术1例,主动脉瓣置换术5例。直视心脏外科手术方法为股动、静脉及右颈静脉插管行体外循环,双腔气管插管。做右胸前外侧切口3~5 cm,经肋间入胸腔,剪开心包,进入心腔完成手术。结果:42例患者全部手术成功,无围手术期及出院后近期死亡,无胸骨切口感染。体外循环时间98~142 min,平均(122.4±23.7)min;主动脉阻断时间0~118 min,平均(48.3±26.2)min。术后气管插管时间8~76 h,平均(17.4±13.1)h,监护时间45~124 h,平均(54.6±32.6)h;术后住院时间6~12 d,平均(8.2±1.3)d。患者切口长度3~7 cm,平均(4.8±1.5) cm;术后第1天引流量(356.9±283.8) ml,未输血患者27例(64.3%)。结论: MIDCS近期效果好,手术安全性高,适用范围广;创伤小,并发症少,切口美观。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号